menu ☰
menu ˟

FDA recalls ranitidine medicines over potential cancer causing impurity

02 Oct 2019

The US Food and Drug Administration has asked doctors and patients to return certain batches of over-the-counter ranitidine tablets (75 mg and 150 mg), after low levels of the probable human...

Click here to view the full article which appeared in BMJ Current